Abstract:ABSTRACT Streptomyces coelicolor CR1 ( Sc CR1) has been shown to be a promising biocatalyst for the synthesis of an atorvastatin precursor, ethyl-( S )-4-chloro-3-hydroxybutyrate [( S )-CHBE]. However, limitations of Sc CR1 observed for practical application include low activity and poor stability. In this work, protein engineering was employed to improve the catalytic efficiency and stability of Sc CR1. First, the crystal structure of Sc CR1 complexed with NADH and cosubstrate 2-propanol was solved, and the specific activity of Sc CR1 was increased from 38.8 U/mg to 168 U/mg ( Sc CR1 I158V/P168S ) by structure-guided engineering. Second, directed evolution was performed to improve the stability using Sc CR1 I158V/P168S as a template, affording a triple mutant, Sc CR1 A60T/I158V/P168S , whose thermostability ( T 50 15 , defined as the temperature at which 50% of initial enzyme activity is lost following a heat treatment for 15 min) and substrate tolerance ( C 50 15 , defined as the concentration at which 50% of initial enzyme activity is lost following incubation for 15 min) were 6.2°C and 4.7-fold higher than those of the wild-type enzyme. Interestingly, the specific activity of the triple mutant was further increased to 260 U/mg. Protein modeling and docking analysis shed light on the origin of the improved activity and stability. In the asymmetric reduction of ethyl-4-chloro-3-oxobutyrate (COBE) on a 300-ml scale, 100 g/liter COBE could be completely converted by only 2 g/liter of lyophilized Sc CR1 A60T/I158V/P168S within 9 h, affording an excellent enantiomeric excess ( ee ) of >99% and a space-time yield of 255 g liter −1 day −1 . These results suggest high efficiency of the protein engineering strategy and good potential of the resulting variant for efficient synthesis of the atorvastatin precursor. IMPORTANCE Application of the carbonyl reductase Sc CR1 in asymmetrically synthesizing ( S )-CHBE, a key precursor for the blockbuster drug Lipitor, from COBE has been hindered by its low catalytic activity and poor thermostability and substrate tolerance. In this work, protein engineering was employed to improve the catalytic efficiency and stability of Sc CR1. The catalytic efficiency, thermostability, and substrate tolerance of Sc CR1 were significantly improved by structure-guided engineering and directed evolution. The engineered Sc CR1 may serve as a promising biocatalyst for the biosynthesis of ( S )-CHBE, and the protein engineering strategy adopted in this work would serve as a useful approach for future engineering of other reductases toward potential application in organic synthesis.

Development of an Engineered Ketoreductase with Improved Activity, Stereoselectivity and Relieved Substrate Inhibition for Enantioselective Synthesis of a Key (R)-Α-lipoic Acid Precursor

Semi-rational Design of Carbonyl Reductase Cat for Synthesis of (R)-Lipoic Acid Precursor

Identification of an ε‐Keto Ester Reductase for the Efficient Synthesis of an (R)‐α‐Lipoic Acid Precursor

Rational Design of Dehydrogenase/Reductases Based on Comparative Structural Analysis of Prereaction-State and Free-State Simulations for Efficient Asymmetric Reduction of Bulky Aryl Ketones

Redesign of a Short-Chain Dehydrogenase/reductase for Asymmetric Synthesis of Ethyl (R)-2-hydroxy-4-phenylbutanoate Based on Per-Residue Free Energy Decomposition and Sequence Conservatism Analysis

Co-evolving the Activity and Thermostability of an ε-Ketoester Reductase for Better Synthesis of (R)-α-Lipoic Acid Precursor.

Enantioselective Synthesis of Structurally Diverse Aryl Γ-/Δ- Lactones Using an Engineered Carbonyl Reductase

Carbonyl Reductase Identification and Development of Whole-Cell Biotransformation for Highly Efficient Synthesis of (R)-[3,5-bis(trifluoromethyl)phenyl] Ethanol

Efficient Synthesis of (R)‐2‐Chloro‐1‐(2,4‐dichlorophenyl)ethanol with a Ketoreductase from Scheffersomyces stipitis CBS 6045

Semi-rational Engineering of Carbonyl Reductase YueD for Efficient Biosynthesis of Halogenated Alcohols with in Situ Cofactor Regeneration

Engineering of a Novel Carbonyl Reductase with Coenzyme Regeneration in E. Coli for Efficient Biosynthesis of Enantiopure Chiral Alcohols.

Highly Efficient Synthesis of Chiral Alcohols with A Novel Nadh-Dependent Reductase from Streptomyces Coelicolor

Engineering Streptomyces Coelicolor Carbonyl Reductase for Efficient Atorvastatin Precursor Synthesis

Development of an Engineered Ketoreductase with Simultaneously Improved Thermostability and Activity for Making a Bulky Atorvastatin Precursor

Asymmetric Bioreduction of Keto Groups of 4- and 5-Oxodecanoic Acids/esters with a New Carbonyl Reductase

Protein engineering of carbonyl reductase for asymmetric synthesis of ticagrelor precursor (1S)-2-chloro-1-(3,4-difluorophenyl)ethanol

Efficient Stereoselective Synthesis of Structurally Diverse Γ‐ and Δ‐lactones Using an Engineered Carbonyl Reductase

Controlling Stereopreferences of Carbonyl Reductases for Enantioselective Synthesis of Atorvastatin Precursor

Stereoselective Synthesis of Chiral Δ-Lactones Via an Engineered Carbonyl Reductase

Efficient synthesis of an ε-hydroxy ester in a space–time yield of 1580gL −1 d −1 by a newly identified reductase Rh CR

Engineering a Carbonyl Reductase to Simultaneously Increase Activity Toward Bulky Ketone and Isopropanol for Dynamic Kinetic Asymmetric Reduction via Enzymatic Hydrogen Transfer